Evidence map›Paper›PMID 34155115›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2021

C1q binding to surface-bound IgG is stabilized by C1r

Seline A Zwarthoff, Kevin Widmer, Annemarie Kuipers, Jürgen Strasser, Maartje Ruyken, Piet C Aerts, Carla J C de Haas, Deniz Ugurlar, Maurits A den Boer, Gestur Vidarsson and 9 more

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 56 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Complement activation by IgG subclasses is governed by their ability to oligomerize upon antigen binding.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  13. Novel FABP4Cell death & disease · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Human anti-C1q autoantibodies bind specifically to solid-phase C1q and enhance phagocytosis but not complement activation.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 2 countries.

Seline A ZwarthoffMedical Microbiology, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, The Netherlands.ORCID 0000-0002-4395-2007
Kevin WidmerPharmaceutical Sciences, University of Basel, 4001 Basel, Switzerland.
Annemarie KuipersMedical Microbiology, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, The Netherlands.
Jürgen StrasserNano Structuring and Bio-Analytics Group, TIMed Center, of Applied Sciences Upper Austria, 4020 Linz, Austria.ORCID 0000-0002-9722-702X
Maartje RuykenMedical Microbiology, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, The Netherlands.ORCID 0000-0003-2289-3412
Piet C AertsMedical Microbiology, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, The Netherlands.
Carla J C de HaasMedical Microbiology, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, The Netherlands.
Deniz UgurlarStructural Biochemistry, Bijvoet Center for Biomolecular Research, Utrecht University, 3584 CH Utrecht, The Netherlands.ORCID 0000-0001-8841-3851
Maurits A den BoerBiomolecular Mass Spectrometry & Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584 CH Utrecht, The Netherlands.ORCID 0000-0002-2608-9395
Gestur VidarssonExperimental Immunohematology, Sanquin Research, 1066 CX Amsterdam, The Netherlands.
Jos A G van StrijpMedical Microbiology, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, The Netherlands.ORCID 0000-0001-6253-0830
Piet GrosStructural Biochemistry, Bijvoet Center for Biomolecular Research, Utrecht University, 3584 CH Utrecht, The Netherlands.ORCID 0000-0002-7782-2585
Paul W H I ParrenImmunohematology and Blood Transfusion, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Kok P M van KesselMedical Microbiology, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, The Netherlands.
Johannes PreinerNano Structuring and Bio-Analytics Group, TIMed Center, of Applied Sciences Upper Austria, 4020 Linz, Austria.ORCID 0000-0002-6755-6543
Frank J BeurskensGenmab, 3584 CT Utrecht, The Netherlands.
Janine SchuurmanGenmab, 3584 CT Utrecht, The Netherlands.ORCID 0000-0002-9738-9926
Daniel RicklinPharmaceutical Sciences, University of Basel, 4001 Basel, Switzerland.ORCID 0000-0001-6140-0233
Suzan H M RooijakkersMedical Microbiology, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, The Netherlands; S.H.M.Rooijakkers@umcutrecht.nl.ORCID 0000-0003-4102-0377
Utrecht University · NLGenmab (Netherlands) · NLUniversity of Basel · CHLeiden University Medical Center · NLSanquin · NL

Funding

Austrian Science Fund FWF P 33958Austrian Science Fund FWF P 34164
6 · The paper itself

Abstract

Complement is an important effector mechanism for antibody-mediated clearance of infections and tumor cells. Upon binding to target cells, the antibody's constant (Fc) domain recruits complement component C1 to initiate a proteolytic cascade that generates lytic pores and stimulates phagocytosis. The C1 complex (C1qr

Indexed as

Cell MembraneComplement ActivationComplement C1qComplement C1rComplement C1sHumansImmunoglobulin GMicroscopy, Atomic ForceMutationPhagocytosisProtein BindingProtein MultimerizationProtein StabilityStaphylococcus aureusComplement C1qComplement C1rComplement C1sImmunoglobulin GC1complementIgG hexamerizationIgG subclassesStaphylococcus aureus

Identifiers

PMID34155115
PMCPMC8256010
OpenAlexW3173200288

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.